These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A comparative study of stimulation of erythropoiesis during renal anemia with the preparation of antibodies against erythropoietin in ultralow doses and Recormon. Epshtein OI, Dygai AM, Zhdanov VV, Sergeeva SA, Zyuz'kov GN, Udut EV, Khrichkova TY, Simanina EV, Gur'yantseva LA, Stavrova LA, Gol'dberg ED. Bull Exp Biol Med; 2007 Jun; 143(6):699-702. PubMed ID: 18239805 [Abstract] [Full Text] [Related]
4. Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia. Osterborg A, Aapro M, Cornes P, Haselbeck A, Hayward CR, Jelkmann W. Eur J Cancer; 2007 Feb; 43(3):510-9. PubMed ID: 17150352 [Abstract] [Full Text] [Related]
11. Selective modulation of the erythropoietic and tissue-protective effects of erythropoietin: time to reach the full therapeutic potential of erythropoietin. Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. Biochim Biophys Acta; 2007 Sep 15; 1776(1):1-9. PubMed ID: 17683868 [Abstract] [Full Text] [Related]
12. Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia. Fan Q, Leuther KK, Holmes CP, Fong KL, Zhang J, Velkovska S, Chen MJ, Mortensen RB, Leu K, Green JM, Schatz PJ, Woodburn KW. Exp Hematol; 2006 Oct 15; 34(10):1303-11. PubMed ID: 16982323 [Abstract] [Full Text] [Related]
13. Effect of ultralow doses of antibodies to erythropoietin on antenatal and postnatal development of the offspring. Borovskaya TG, Loskutova OP, Abramova EV, Sergeeva SA, Epstein OI, Dygai AM, Goldberg ED. Bull Exp Biol Med; 2003 Jan 15; 135 Suppl 7():77-9. PubMed ID: 12949658 [Abstract] [Full Text] [Related]
16. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin. Sato T, Maekawa T, Watanabe S, Tsuji K, Nakahata T. J Clin Invest; 2000 Jul 15; 106(2):263-70. PubMed ID: 10903342 [Abstract] [Full Text] [Related]
17. Erythropoietin mimetic peptides and erythropoietin fusion proteins for treating anemia of chronic kidney disease. Gupta N, Wish JB. Curr Opin Nephrol Hypertens; 2018 Sep 15; 27(5):345-350. PubMed ID: 29746307 [Abstract] [Full Text] [Related]
18. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia. Rosen BS, Levine EA, Egrie JC, Sehgal LR, Greenberg R, Rosen AL, Levine HD, Gould SA. Exp Hematol; 1993 Oct 15; 21(11):1487-91. PubMed ID: 8405228 [Abstract] [Full Text] [Related]
19. Identification of erythroid progenitors induced by erythropoietic activity in Xenopus laevis. Nogawa-Kosaka N, Sugai T, Nagasawa K, Tanizaki Y, Meguro M, Aizawa Y, Maekawa S, Adachi M, Kuroki R, Kato T. J Exp Biol; 2011 Mar 15; 214(Pt 6):921-7. PubMed ID: 21346119 [Abstract] [Full Text] [Related]
20. In vivo regulation of erythropoiesis by chemically inducible dimerization of the erythropoietin receptor intracellular domain. Suzuki N, Mukai HY, Yamamoto M. PLoS One; 2015 Mar 15; 10(3):e0119442. PubMed ID: 25790231 [Abstract] [Full Text] [Related] Page: [Next] [New Search]